Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective
© 2017 Informa UK Limited, trading as Taylor & Francis Group. Aims: An economic evidence is a vital tool that can inform the decision to use costly insulin analogs. This study aimed to evaluate long-term cost-effectiveness of insulin detemir (IDet) compared with insulin glargine (IGlar) in typ...
Saved in:
Main Authors: | Permsuwan U., Thavorn K., Dilokthornsakul P., Saokaew S., Chaiyakunapruk N. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85023172990&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective
by: Unchalee Permsuwan, et al.
Published: (2018) -
Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
by: Permsuwan U., et al.
Published: (2017) -
Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Permsuwan U., et al.
Published: (2017)